Autori: Zimran An
| Naslov | Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease (Article) |
| Autori | van Dussen Laura Zimran An Akkerman EM Aerts JMFG Petakov Milan S Elstein Deborah Rosenbaum H Aviezer David Brill-Almon Einat Chertkoff Raul Maas M Hollak CEM |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2013), vol. 50 br. 3, str. 206-211 |
| Projekat | Protalix Biotherapeutics |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
| Naslov | Significant, Continuous Improvement in Bone Mineral Density (Bmd) Among Type 1 Gaucher Disease Patients Treated with Velaglucerase Alfa: 69-Month Experience, Including Dose Reduction (Meeting Abstract) |
| Autori | Elstein Deborah Foldes Joseph A Zahrieh David Cohn Gabriel M Djordjevic Maja S Brutaru Costin Zimran An |
| Info | JOURNAL OF INHERITED METABOLIC DISEASE, (2011), vol. 34 br. , Suppl. 3, str. S223-S223 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Significant, continuous improvement in Bone Mineral Density (BMD) among type 1 Gaucher disease patients treated with Velaglucerase Alfa: 69-month experience, including dose reduction (Meeting Abstract) |
| Autori | Elstein Deborah Foldes Joseph A Zahrieh David Cohn Gabriel M Djordjevic Maja S Brutaru Costin Zimran An |
| Info | MOLECULAR GENETICS AND METABOLISM, (2011), vol. 102 br. 2, str. S17-S18 |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease (Article) |
| Autori | Elstein Deborah Cohn Gabriel M Wang N Djordjevic Maja S Brutaru Costin Zimran An |
| Info | BLOOD CELLS MOLECULES AND DISEASES, (2011), vol. 46 br. 1, str. 119-123 |
| Projekat | Shire Human Genetic Therapies ; Genzyme Corporation ; Shire HGT |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
